Clinical Trials Directory

Trials / Recruiting

RecruitingNCT01484730

A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

A Pilot Study to Evaluate Multi-Spectral Imaging (MI) and Laser Speckle Imaging (LSI) and Multiphoton Microscopy (MPM) During Vascular Occlusion

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is to evaluate and validate the performance of non-invasive imaging modalities for assessment of skin. A pressure cuff occlusion will be used to stimulate blood flow dynamic that these instruments are designed to sense. The researcher currently plan to assess only basic feasibility of the imaging instruments.

Detailed description

The primary reason for including pressure cuff occlusion in this protocol is to test the performance of Multi-Spectral Imaging and Laser Speckle Imaging can measure in the full range of vascular conditions ranging from ischemic (under-perfused or unsaturated) to hyperemic (over-perfused and over-saturated). 1. Modulated Imaging a non-contact optical imaging technology can detect the concentration of total hemoglobin, deoxygenated and oxygenated hemoglobin in absolute amounts in units of millimoles / unit volume of tissue measured. 2. Laser Speckle Imaging a non-contact optical imaging technology consists of a coherent light source, camera, and image acquisition system. This image device can measure and compare relative flow in vasculature at varied time points.

Conditions

Interventions

TypeNameDescription
DEVICEMulti-Spectral and Laser Speckle ImagingChanges in skin tissue and blood flow.

Timeline

Start date
2011-11-01
Primary completion
2026-08-01
Completion
2028-08-01
First posted
2011-12-02
Last updated
2025-12-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01484730. Inclusion in this directory is not an endorsement.